Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

BACKGROUND: Prostate cancer is one of the most common cancers in men and the fourth leading cause of cancer mortality worldwide. Although major progress has been achieved in the last years for patients with metastatic castrate-resistant prostate cancer (mCRPC), thanks to next-generation androgen rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Cabel, Luc, Loir, Elika, Gravis, Gwenaelle, Lavaud, Pernelle, Massard, Christophe, Albiges, Laurence, Baciarello, Giulia, Loriot, Yohann, Fizazi, Karim
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5394619/
https://ncbi.nlm.nih.gov/pubmed/28428880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0232-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados